financetom
Business
financetom
/
Business
/
Delta Air Lines Offers Upbeat Earnings Outlook as Third-Quarter Results Top Views
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Delta Air Lines Offers Upbeat Earnings Outlook as Third-Quarter Results Top Views
Oct 9, 2025 8:05 AM

10:30 AM EDT, 10/09/2025 (MT Newswires) -- Delta Air Lines ( DAL ) issued an upbeat fourth-quarter earnings outlook on Thursday amid improving sales trends, while the air carrier's results in the prior-three month period topped market estimates.

The company expects adjusted earnings to be in a range of $1.60 to $1.90 per share for the ongoing quarter. The midpoint of the guidance is above the current consensus on FactSet of $1.65. The stock jumped 6.6% in Thursday trade.

Revenue is projected to rise by 2% to 4% year over year in the fourth quarter, "with healthy sequential unit revenue improvement driven by continued domestic strength and meaningful improvement in transatlantic unit revenue," President Glen Hauenstein said in a statement. The Street is looking for $14.71 billion in sales.

"Over the last six weeks, sales trends have accelerated across all geographies and in every advance purchase window, positioning Delta to finish the year with momentum," Hauenstein added.

For full-year 2025, Delta now anticipates adjusted EPS of about $6, in the upper half of the forecast it provided in July. At the time, the company expected adjusted EPS between $5.25 to $6.25. The average analyst estimate on FactSet is for $5.80.

"Looking to 2026, Delta is well positioned to deliver top-line growth, margin expansion and earnings improvement consistent with our long-term financial framework," according to Chief Executive Ed Bastian.

For the September quarter, the airline's adjusted EPS climbed 14% to $1.71, surpassing the market's view for $1.53. Adjusted operating revenue improved 4.1% to $15.2 billion, beating the Street's estimate of $15.08 billion, buoyed by a 9% jump in the premium segment. Delta also benefited from "improving domestic fundamentals," Hauenstein said.

Adjusted total revenue per available seat mile edged 0.3% higher year over year. Overall passenger revenue increased 3%, while cargo climbed by 19%.

Non-fuel cost per available seat mile nudged 0.3% higher on a yearly basis, bringing the year-to-date unit cost growth to less than 2%, which is consistent with the carrier's low-single-digit outlook at the start of the year, Chief Financial Officer Dan Janki said.

Price: 60.86, Change: +3.74, Percent Change: +6.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Nationwide to acquire Allstate's stop-loss insurance business in $1.25 billion deal
Jan 30, 2025
Jan 30 (Reuters) - U.S. insurer Nationwide said on Thursday that it would acquire property and casualty insurer Allstate Corp's ( ALL ) employer stop-loss segment in a $1.25 billion deal, as it seeks to expand its stop-loss insurance offering. The transaction is expected to close in the second half of 2025, Nationwide said in a statement. Stop-loss insurance serves...
Biotech firm Maze Therapeutics raises $140 million in US IPO
Biotech firm Maze Therapeutics raises $140 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech listing this year. Maze priced the offering at $16 per share, within its indicated range of $15 to $17. ...
Weight-loss drug developer Metsera raises $275 million in US IPO
Weight-loss drug developer Metsera raises $275 million in US IPO
Jan 30, 2025
Jan 30 (Reuters) - Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company said on Thursday. ...
Apple shares rise after positive sales outlook signals iPhone recovery
Apple shares rise after positive sales outlook signals iPhone recovery
Jan 30, 2025
(Reuters) -Apple executives on Thursday forecast relatively strong sales growth, a sign the company will recover from a dip in iPhone sales as it rolls out artificial intelligence features. The forecast comes after Apple delivered a slight drop in iPhone revenues for the holiday shopping quarter and lagged Wall Street estimates, hampered by a lack in some markets of artificial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved